Application of serum exosomal miRNA markers in the early diagnosis of endemic arsenicosis
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- NANJING MEDICAL UNIV
- Publication Date
- 2019-01-22
- Estimated Expiration
- Not applicable Β· inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of genetic engineering and clinical medicine, and specifically relates to serum exosome microRNAs (miRNAs) markers and applications thereof related to the early occurrence of endemic arsenicosis in humans. Background technique
[0002] Endemic arsenicosis, referred to as ground arsenic disease, is a biogeochemical disease, which is caused by the loss of skin pigmentation caused by long-term intake of excessive inorganic arsenic through drinking water, air or food by residents living in a specific geographical environment. Or / and excessive sedation, palmoplantar keratosis and cancerous systemic chronic poisoning. Arsenicosis is an endemic disease that seriously endangers human health. In addition to causing skin changes, inorganic arsenic is a human carcinogen identified by the International Center for Cancer Research, which can cause skin cancer, lung cancer, and high incidence of other visceral cancers. I...